Shinpoong Pharmaceutical Co.,Ltd
Research Shinpoong Pharmaceutical Co.,Ltd (019170.KS) on Bullrun: market cap KRW 515.52B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker019170.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 515.52B
- Financial periodQ2 2026
- RevenueKRW 63.89B
- Net income-KRW 8.01B
- Free cash flow-KRW 2.94B
- Gross margin42.2%
Valuation Snapshot
latest market cap is KRW 515.52B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 515.52B | n/a | n/a | n/a |
About Shinpoong Pharmaceutical Co.,Ltd
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug;
ETFs that hold Shinpoong Pharmaceutical Co.,Ltd
US-listed ETFs
Shinpoong Pharmaceutical Co.,Ltd is held by 12 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard FTSE Developed Markets Index Fund ETF Shares (VEA) | <0.01% | 0.03% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| State Street SPDR Portfolio Developed World ex-US ETF (SPDW) | <0.01% | 0.03% |
| Vanguard FTSE Pacific Index Fund ETF Shares (VPL) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | 0.01% | 0.06% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
Portfolios as filed with the SEC on Form N-PORT, dated June to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Shinpoong Pharmaceutical Co.,Ltd's market cap?
Shinpoong Pharmaceutical Co.,Ltd's market capitalization is KRW 515.52B.
What does Shinpoong Pharmaceutical Co.,Ltd do?
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics.